Physician profile
Kate E Paylo
NPI 1447287958
$2,495.02
in general payments reported to CMS, 2019-2025
24 companies · $1,803 in 2025
The $1,803 reported for 2025 was more than what 84% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $133 · 2021: $12.24 · 2022: $62.40 · 2023: $49.63 · 2024: $35.44 · 2025: $1,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,295 · Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,294.52 |
| Food and Beverage | $593.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $930.11 | 2025 | |
| Cgg Medical INC | $828.89 | 2025 | |
| Tersera Therapeutics LLC | $129.45 | 2019 | |
| Boston Scientific Corporation | $100.66 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $45.00 | 2019 | |
| Pacira Therapeutics, INC. | $43.62 | 2019-2020 | |
| Nevro Corp. | $41.94 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.31 | 2019 | |
| Ferring Pharmaceuticals INC. | $35.44 | 2024 | Euflexxa |
| Collegium Pharmaceutical, INC. | $32.20 | 2019-2025 | Xtampza |
| Medtronic USA, INC. | $30.93 | 2019 | |
| Depuy Synthes Sales INC. | $28.14 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2025 | |
| Kaleo, INC. | $23.06 | 2019 | |
| Medtronic Vascular, INC. | $22.49 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.54 | 2020 | |
| Flowonix Medical Incorporated | $17.38 | 2020 | |
| Scilex Pharmaceuticals INC. | $17.04 | 2023 | Ztlido |
| Painteq LLC | $16.30 | 2023 | Painteq |
| Teva Pharmaceuticals USA, INC. | $15.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.91 | 2019 | |
| Nalu Medical, INC. | $14.09 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $12.80 | 2019 | |
| Shionogi INC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Paylo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.